Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus - Wikidata - awgldk - TriplyDB

Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus

Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus

http://www.wikidata.org/entity/Q28755816

about

sameAs

Thunder and lightning: immunotherapy and oncolytic viruses collide Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy Oncolytic Viruses: Therapeutics With an Identity Crisis Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade Oncolytic viruses: finally delivering The evolution of poxvirus vaccines The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications Oncolytic virotherapy for pediatric malignancies: future prospects Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer Targeting tumor vasculature with an oncolytic virus.Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF.Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors.Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection.Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses Oncolytic viruses: From bench to bedside with a focus on safety.Targeting pediatric cancer stem cells with oncolytic virotherapy Preferential colonization of metastases by oncolytic vaccinia virus strain GLV-1h68 in a human PC-3 prostate cancer model in nude mice.Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer.Gene therapy progress and prospects cancer: oncolytic viruses.Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma model Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer.The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers.Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicity.Effective oncolytic vaccinia therapy for human sarcomas.Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.The immunologic aspects of poxvirus oncolytic therapy Oncolytic viruses in the treatment of bladder cancer Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy Features of the Antitumor Effect of Vaccinia Virus Lister Strain Regulating cytokine function enhances safety and activity of genetic cancer therapies Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activity.Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effects.Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases

P2860

Q24597894-95D9BA32-573B-4672-B949-5517AAD6F538 Q24605512-42426B49-638B-4CC4-9CDD-1C15BDA3A9D6 Q26741020-C1E7B179-51C7-43A6-BB8B-C29C69D395E6 Q26769977-5276B4FC-FA47-4B3A-B336-864504C4EE0F Q26772039-23B311C6-1BD6-495D-B663-F0C8105175EE Q26995905-C98C8B76-2C7A-4745-9A68-A81144032495 Q27002660-7FB8EAA5-D009-49A8-A016-C688B12343C1 Q28069358-ECD0C7A4-3ADB-4E34-BA95-ED817174FB2B Q28078939-BC4AE6D9-5D0D-428A-A1A0-DDCC6775B79C Q30500348-B758F118-D9DC-41F4-BD88-AB036ED1F369 Q33370547-BCC20E3B-A330-4512-810E-00A918BDE665 Q33769835-23000760-5687-444E-9D32-EA7447CA7C82 Q33808504-B37B72BF-1C1C-41D4-A997-6983C9B3B632 Q33820196-9FF13920-DC35-404A-B973-645BBD82F2E6 Q33906116-42A0095E-F766-4A63-8F8E-A99CBD809E0D Q33924550-B8F3BD54-D761-4976-AF1E-373F6244DD2D Q34044071-E8E7408C-68B8-458E-9253-A8FACF79AFE1 Q34262327-45285C6E-E61F-4646-B3C6-A6D7AC7611A7 Q34438608-DA2803D6-B9C4-453B-80D9-77D482B6A20E Q34473301-D204B24B-3694-4E3B-87F6-36828BD64A57 Q34757261-05B88150-81A6-466A-8460-FE18CB435A41 Q34770611-44602D42-9D37-4946-A9A5-E8C3C18C6A6C Q34777479-324E451D-537D-42E0-9B14-2362DD8A9BC1 Q35086690-62045EE0-B6D2-44A1-9AD3-F6A92991AB93 Q35226109-55CE93DA-A05E-492D-85DC-398C7C4E0622 Q35338417-A8E00B5B-AB6C-42A7-8404-E643B7C7049C Q35647212-64423015-B710-4E69-B807-057BD2B1EB2F Q35876204-41CCEE0F-68F8-44FF-9C47-F8EE5600622D Q35876239-05186921-A597-4654-B06F-F5F25E37E612 Q35954052-0BCAC5A8-CA1F-4D60-8760-DDE8A690E367 Q36049446-4E9461CD-CF43-4967-8ADD-EF23A083B6A1 Q36099082-9D9D2C04-F139-4612-9316-8227BACF15AA Q36115128-5CE8093A-7A5E-4A55-9D91-CE9C6BAD71B8 Q36147934-A0942F15-879D-49DF-811B-936370EE9FFA Q36378248-7A246620-F385-4F58-A42F-CF95CFE86542 Q36507293-A0BC07C6-543F-47D8-B14D-1AB8BA66DA82 Q36512561-F4E1ED88-7004-4259-9CD6-AC6991BA0D57 Q36520695-91D7210D-D00F-4F04-AFCF-EA8CA7299086 Q36659289-10589BD6-16A2-4358-A62A-76F02800131E Q36747524-8FAAADFB-C225-48D1-9742-BC82D9F62672

P2860

Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus

http://www.wikidata.org/entity/Q28755816

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@ast

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@en

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@nl

type

label

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@ast

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@en

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@nl

prefLabel

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@ast

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@en

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@nl

P1433

Q28755816-1817204A-4AAA-4250-8C12-5CFAF89775F7

P1476

Q28755816-956E770D-6B8F-4BBB-8B17-270CF65BF8A1

P2093

Q28755816-87E7FF3A-1F1F-422D-89D2-7BEA6B60558E

Q28755816-AB0FA49D-D6F7-4E68-8683-33523257689D

Q28755816-C4BB03D2-0B2C-412D-BFDC-7EB4AFAB9519

Q28755816-DEBC1967-DB93-4C91-A8EF-8610A78EA4AC

P2860

Q28755816-10D03408-1DAA-430C-9740-E622686DC1CB

Q28755816-147768A9-B324-4341-B3B4-5418F6FE4828

Q28755816-14E3021F-2CDC-4CC5-A412-560964210C90

Q28755816-21FB40D2-4BB3-42DD-BD6B-7B020DF3B4E0

Q28755816-23FB4160-1EAB-42CC-A38E-FB20C667F7E5

Q28755816-349611E1-96FB-4267-8C14-E3859E0DE8CA

Q28755816-36A108EC-3A06-4AB8-88E7-81FE33AD84EA

Q28755816-3834CF75-4F8B-4B8B-AEEA-1DB73F0CD029

Q28755816-446D03C2-6A5B-480F-B849-BE1D7A6867A7

Q28755816-5164BA04-C419-4A8A-91A4-CCEC4F50773E

P304

Q28755816-4B103739-0265-4D90-888D-8694B23228BA

P31

Q28755816-0FECCC0B-D196-4259-9D2B-3743611D68BF

P3181

Q28755816-7C64BDD6-0C47-4C31-967E-107287CFCB87

P356

Q28755816-0A189F92-F0D6-470C-BDA3-196DB6C7C4FB

P407

Q28755816-F5C22C08-AF20-49A5-8604-BBEA1577FDE9

P433

Q28755816-68A95D73-6687-4600-9B1B-B7F9A364DE19

P478

Q28755816-565D29D8-243E-411D-BFD1-D7257CD15889

P50

Q28755816-214EF74C-99F5-4D07-9A51-8902CEFD9B3E

P577

Q28755816-F8709C53-2C0B-4A04-81D9-FA0130866B67

P5875

Q28755816-CBDA5F5D-F2EB-4C75-8606-A3A5A580B985

P698

Q28755816-6C76CA91-CA8A-481E-840D-6F33FAA898AE

P921

Q28755816-797F4ADD-ACCA-4C6B-92AD-E5145A59C660

P932

Q28755816-67BDFCA8-B9E2-4AB4-915B-158383606183

P3181

P356

JOURNAL.PMED.0040353

P1433

P1476

Targeting of interferon-beta t ...... istic oncolytic vaccinia virus

@en

P2093

David H Kirn

http://www.w3.org/2001/XMLSchema#string

Fabrice Le Boeuf

http://www.w3.org/2001/XMLSchema#string

Steve H Thorne

http://www.w3.org/2001/XMLSchema#string

Yaohe Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.

Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions.

Interferon production in glia and glioma cell lines

Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF.

RNA viruses as virotherapy agents.

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.

Interferon-beta gene therapy for cancer: basic research to clinical application.

P304

e353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3734379

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0040353

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5687523

http://www.w3.org/2001/XMLSchema#string

P698

18162040

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

2222946

http://www.w3.org/2001/XMLSchema#string